Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 08-Feb-24 5:09 PM View:  | Tyra Biosciences, Inc. (TYRA) | 06-Feb-24 | Grant | 63,412 | $13.01 | $824,990.00 | < 1% 6.47M to 6.53M | (6%) |
| 25-Jan-24 4:32 PM View: | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 287,866 | -- | -- | (4%) 6.86M to 6.57M | |
| 25-Jan-24 4:32 PM View: | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 3,201,440 | -- | -- | (49%) 6.57M to 3.37M | |
| 25-Jan-24 4:32 PM View: | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 3,370,240 | -- | -- | (100%) 3.37M to 0 | |
| 17-Oct-23 6:04 PM View: | Tango Therapeutics, Inc. (TNGX) | 16-Oct-23 | Purchase | 500,000 | $6.84 | $3,420,000.00 | 3% 15.41M to 15.91M | |
| 17-Oct-23 6:04 PM View: | Tango Therapeutics, Inc. (TNGX) | 13-Oct-23 | Private Purchase | 750,000 | $7.07 | $5,302,500.00 | 5% 14.66M to 15.41M | |
| 11-Oct-23 9:22 PM View: | Tango Therapeutics, Inc. (TNGX) | 09-Oct-23 | Market Sale | 50,000 | $9.91 | $495,500.00 | (< 1%) 14.89M to 14.84M | (3%) |
| 11-Oct-23 9:22 PM View: | Tango Therapeutics, Inc. (TNGX) | 09-Oct-23 | Market Sale | 175,000 | $9.97 | $1,744,750.00 | (1%) 14.84M to 14.66M | (2%) |
| 25-Aug-23 9:28 PM View: | Iteos Therapeutics, Inc. (ITOS) | 23-Aug-23 | Sale | 350,000 | $16.26 | $5,692,670.00 | (16%) 2.15M to 1.8M | |
| 15-Aug-23 9:38 PM View: | Mirati Therapeutics, Inc. (MRTX) | 11-Aug-23 | Private Purchase | 57,533 | $27.80 | $1,599,420.00 | 1% 5.41M to 5.47M | |
| 15-Aug-23 9:38 PM View: | Mirati Therapeutics, Inc. (MRTX) | 11-Aug-23 | Purchase | 1,201,440 | $27.80 | $33,400,000.00 | 22% 5.47M to 6.67M | |
| 15-Aug-23 9:39 PM View: | Mirati Therapeutics, Inc. (MRTX) | 11-Aug-23 | Private Purchase Duplicate | 57,533 | $27.80 | $1,599,420.00 | 1% 5.41M to 5.47M | |
| 15-Aug-23 9:39 PM View: | Mirati Therapeutics, Inc. (MRTX) | 11-Aug-23 | Purchase Duplicate | 1,201,440 | $27.80 | $33,400,000.00 | 22% 5.47M to 6.67M | |
| 15-Aug-23 9:34 PM View: | Tango Therapeutics, Inc. (TNGX) | 11-Aug-23 | Private Purchase | 475,000 | $5.15 | $2,446,250.00 | 3% 14.41M to 14.89M | |
| 24-May-23 8:05 PM View: | Rain Oncology Inc. (RAIN) | 22-May-23 | Sale | 995,000 | $1.25 | $1,243,750.00 | (46%) 2.15M to 1.15M | |
| 13-Oct-22 9:30 PM View: | Tango Therapeutics, Inc. (TNGX) | 13-Oct-22 | Purchase | 70,000 | $4.65 | $325,227.00 | < 1% 7.32M to 7.39M | |
| 13-Oct-22 9:30 PM View: | Tango Therapeutics, Inc. (TNGX) | 12-Oct-22 | Purchase | 50,000 | $4.43 | $221,640.00 | < 1% 7.27M to 7.32M | |
| 13-Oct-22 9:30 PM View: | Tango Therapeutics, Inc. (TNGX) | 11-Oct-22 | Private Purchase | 117,000 | $4.25 | $497,706.00 | 2% 7.16M to 7.27M | |
| 06-Oct-22 9:15 PM View: | Tango Therapeutics, Inc. (TNGX) | 06-Oct-22 | Purchase | 70,394 | $4.06 | $286,067.00 | 1% 6.98M to 7.05M | |
| 06-Oct-22 9:15 PM View: | Tango Therapeutics, Inc. (TNGX) | 05-Oct-22 | Purchase | 86,000 | $3.88 | $334,053.00 | 1% 6.9M to 6.98M | |
| 06-Oct-22 9:15 PM View: | Tango Therapeutics, Inc. (TNGX) | 04-Oct-22 | Private Purchase | 25,606 | $3.67 | $93,976.60 | < 1% 6.87M to 6.9M | |
| 18-Mar-22 9:00 PM View: | Iteos Therapeutics, Inc. (ITOS) | 17-Mar-22 | Sale | 575,201 | $35.25 | $20,275,800.00 | (15%) 3.72M to 3.14M | |
| 05-Jan-22 9:20 PM View: | Iteos Therapeutics, Inc. (ITOS) | 04-Jan-22 | Market Sale | 184,677 | $42.77 | $7,898,260.00 | (5%) 3.9M to 3.72M | 2% |
| 05-Jan-22 9:20 PM View: | Iteos Therapeutics, Inc. (ITOS) | 03-Jan-22 | Market Sale | 515,323 | $47.89 | $24,677,400.00 | (12%) 4.42M to 3.9M | 12% |
| 21-Dec-21 5:00 PM View: | Tyra Biosciences, Inc. (TYRA) | 17-Dec-21 | Market Purchase | 125,000 | $13.12 | $1,640,310.00 | 2% 6.32M to 6.45M | (7%) |
| 24-Nov-21 6:00 PM View: | Odonate Therapeutics, Inc. (ODT) | 24-Nov-21 | Market Sale | 200,000 | $1.57 | $313,680.00 | (5%) 4.41M to 4.21M | 4% |
| 24-Nov-21 6:00 PM View: | Odonate Therapeutics, Inc. (ODT) | 22-Nov-21 | Market Sale | 200,000 | $1.55 | $309,660.00 | (4%) 4.61M to 4.41M | 3% |
| 19-Nov-21 7:21 PM View: | Odonate Therapeutics, Inc. (ODT) | 19-Nov-21 | Market Sale | 150,000 | $1.84 | $276,285.00 | (3%) 4.76M to 4.61M | (< 1%) |
| 19-Nov-21 7:21 PM View: | Odonate Therapeutics, Inc. (ODT) | 18-Nov-21 | Market Sale | 250,000 | $1.95 | $487,250.00 | (5%) 5.01M to 4.76M | 5% |
| 19-Nov-21 7:21 PM View: | Odonate Therapeutics, Inc. (ODT) | 17-Nov-21 | Market Sale | 600,000 | $2.17 | $1,299,240.00 | (11%) 5.61M to 5.01M | 15% |
| 17-Sep-21 4:38 PM View: | Tyra Biosciences, Inc. (TYRA) | 17-Sep-21 | Conversion | 5,986,450 | -- | -- | 100% 0 to 5.99M | |
| 17-Sep-21 4:38 PM View: | Tyra Biosciences, Inc. (TYRA) | 17-Sep-21 | Private Purchase | 625,000 | $16.00 | $10,000,000.00 | 10% 5.99M to 6.61M | |
| 27-Apr-21 5:11 PM View: | Rain Oncology Inc. (RAIN) | 27-Apr-21 | Market Purchase | 1,025,000 | $17.00 | $17,425,000.00 | 683% 150.0K to 1.18M | |
| 27-Apr-21 5:11 PM View: | Rain Oncology Inc. (RAIN) | 23-Apr-21 | Purchase | 150,000 | $16.16 | $2,423,250.00 | 100% 0 to 150.0K | |
| 09-Mar-21 9:48 PM View: | Mirati Therapeutics, Inc. (MRTX) | 05-Mar-21 | Option Exercise | 611,440 | $0.00 | $611.44 | 30% 2.02M to 2.63M | |
| 09-Mar-21 9:48 PM View: | Mirati Therapeutics, Inc. (MRTX) | 05-Mar-21 | Market Option Sale | 400,005 | $181.15 | $72,460,896.00 | (15%) 2.63M to 2.23M | |
| 30-Dec-20 6:19 PM View: | Odonate Therapeutics, Inc. (ODT) | 30-Dec-20 | Market Purchase | 100,000 | $17.46 | $1,746,380.00 | 2% 5.51M to 5.61M | (1%) |
| 30-Dec-20 6:19 PM View: | Odonate Therapeutics, Inc. (ODT) | 28-Dec-20 | Market Purchase | 300,000 | $17.06 | $5,117,050.00 | 6% 5.21M to 5.51M | 1% |
| 30-Oct-20 9:54 PM View: | Mirati Therapeutics, Inc. (MRTX) | 30-Oct-20 | Payment of Exercise | 3 | $219.97 | $659.91 | (< 1%) 2.42M to 2.42M | (7%) |
| 30-Oct-20 9:54 PM View: | Mirati Therapeutics, Inc. (MRTX) | 30-Oct-20 | Option Exercise | 400,003 | $0.00 | $400.00 | 20% 2.02M to 2.42M | |
| 30-Oct-20 9:54 PM View: | Mirati Therapeutics, Inc. (MRTX) | 30-Oct-20 | Market Option Sale | 400,000 | $202.00 | $80,800,000.00 | (17%) 2.42M to 2.02M | (16%) |
| 30-Sep-20 4:31 PM View: | Odonate Therapeutics, Inc. (ODT) | 29-Sep-20 | Market Purchase | 122,000 | $14.08 | $1,717,760.00 | 2% 5.09M to 5.21M | 23% |
| 29-Sep-20 4:40 PM View: | Pmv Pharmaceuticals, Inc. (PMVP) | 29-Sep-20 | Conversion | 1,318,240 | -- | -- | 139% 950.0K to 2.27M | |
| 29-Sep-20 4:40 PM View: | Pmv Pharmaceuticals, Inc. (PMVP) | 29-Sep-20 | Conversion | 60,837 | -- | -- | 3% 2.27M to 2.33M | |
| 30-Sep-20 4:31 PM View: | Odonate Therapeutics, Inc. (ODT) | 28-Sep-20 | Market Purchase | 93,200 | $13.03 | $1,214,400.00 | 2% 4.99M to 5.09M | 32% |
| 29-Sep-20 4:40 PM View: | Pmv Pharmaceuticals, Inc. (PMVP) | 25-Sep-20 | Purchase | 950,000 | $18.00 | $17,100,000.00 | 100% 0 to 950.0K | |
| 09-Sep-20 5:59 PM View: | Odonate Therapeutics, Inc. (ODT) | 09-Sep-20 | Market Purchase | 81,100 | $15.20 | $1,232,720.00 | 2% 4.91M to 4.99M | 14% |
| 09-Sep-20 5:59 PM View: | Odonate Therapeutics, Inc. (ODT) | 08-Sep-20 | Market Purchase | 18,800 | $14.69 | $276,172.00 | < 1% 4.89M to 4.91M | 17% |
| 09-Sep-20 5:59 PM View: | Odonate Therapeutics, Inc. (ODT) | 04-Sep-20 | Market Purchase | 125,100 | $14.89 | $1,862,740.00 | 3% 4.77M to 4.89M | 16% |
| 01-Sep-20 4:30 PM View: | Odonate Therapeutics, Inc. (ODT) | 28-Aug-20 | Private Purchase | 1,403,510 | $14.25 | $20,000,000.00 | 42% 3.36M to 4.77M |